{"uid":"cap_q-DUuNFFGlC4VugV1njRh","slug":"fda-adverse-events-drug-safety-faers-ema-dbed0ed7","name":"FDA Adverse Events Drug Safety (FAERS + EMA)","description":"FDA drug adverse events (FAERS) and drug safety for one drug: boxed warning, recalls and shortages (openFDA), plus EU authorisation and shortages (EMA). Not medical advice. Typical call $0.02: $0.004 per drug query, $0.02 per dossier, min $0.005. upto: pay only for delivered rows; exact: pays the quote. Nothing is settled on an error or empty result. By Bosco Labs: official sources, source link per row.","url":"https://api.boscolabs.dev/v1/drug-safety?utm_source=zero.xyz","method":"POST","headers":{},"bodySchema":{"type":"object","properties":{"drug":{"type":"string","pattern":"^[^\\[\\]{}<>\\r\\n]*$","description":"One drug: generic name, active ingredient or brand, e.g. \"semaglutide\", \"metformin\" or \"Ozempic\""},"mode":{"enum":["dossier","label","adverse_events_top","recalls","shortages","eu_status"],"type":"string","default":"dossier","description":"\"dossier\" (default) fills all five sections in one call and costs $0.02"},"maxItems":{"type":"integer","default":10,"maximum":50,"minimum":1,"description":"Cap on each list in the row: top FAERS reactions, recalls"}}},"responseSchema":{"type":"json","example":{"rows":[{"drug":{"matched_as":"generic","search_term":"semaglutide","generic_name":"SEMAGLUTIDE","fda_labels_matching":5},"mode":"dossier","label":{"routes":["SUBCUTANEOUS"],"set_id":"42bdd912-2393-44c4-b7e0-47672ca28991","label_url":"https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42bdd912-2393-44c4-b7e...","source_url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name.exact%3A%22SE...","brand_names":["Ozempic"],"indications":"OZEMPIC is indicated: • as an adjunct to diet and exercise to improve glycemi...","provided_by":"Bosco Labs (boscolabs.dev)","generic_name":"SEMAGLUTIDE","manufacturer":"A-S Medication Solutions","product_type":"HUMAN PRESCRIPTION DRUG","boxed_warning":"WARNING: RISK OF THYROID C-CELL TUMORS • In rodents, semaglutide causes dose-...","effective_date":"2026-07-30","labels_matching":4,"has_boxed_warning":true,"application_number":"NDA209637","pharmacologic_class":["GLP-1 Receptor Agonist [EPC]"]},"query":"semaglutide","notice":"Not medical advice. Information for research and reference only; do not use i...","recalls":{"total":57,"recalls":[{"status":"Ongoing","report_date":"2026-10-14","recall_number":"D-0026-2027","classification":"Class II","recalling_firm":"Carolina Infusion, LLC","reason_for_recall":"Lack of Assurance of Sterility: Related to formulation using bacteriostic wat...","voluntary_mandated":"Voluntary: Firm initiated","product_description":"SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosag...","recall_initiation_date":"2026-09-10"}],"source_url":"https://api.fda.gov/drug/enforcement.json?search=openfda.generic_name%3A%22se...","provided_by":"Bosco Labs (boscolabs.dev)","data_last_updated":"2026-10-28"},"related":{"clinical_trials":{"why":"Trials testing this drug (status, phase, sponsor, read-out dates).","actor":"bosco_labs/clinical-trials","input":{"intervention":"semaglutide"}}},"warnings":[],"eu_status":{"products":[{"name":"Kayshild","status":"Authorised","generic":false,"atc_code":"A10BJ06","epar_url":"https://www.ema.europa.eu/en/medicines/human/EPAR/kayshild","biosimilar":false,"last_updated":"2026-04-09","orphan_medicine":false,"active_substance":"semaglutide","therapeutic_area":"Non-alcoholic Fatty Liver Disease;Liver Cirrhosis","authorisation_date":"2026-03-26","conditional_approval":true,"additional_monitoring":true,"withdrawn_or_expired_date":null,"marketing_authorisation_holder":"Novo Nordisk A/S"}],"shortages":[{"status":"Shortage resolved","start_date":null,"last_updated":"2026-01-13","shortage_url":"https://www.ema.europa.eu/en/medicines/human/shortages/ozempic","forms_affected":"Pre-filled pen","medicine_affected":"Ozempic","expected_resolution":null,"alternatives_available":true}],"source_url":"https://www.ema.europa.eu/en/documents/report/medicines-output-medicines_json...","provided_by":"Bosco Labs (boscolabs.dev)","data_timestamp":"2026-11-06T06:01:41Z","products_total":5,"shortages_total":2,"authorised_products":5,"shortages_source_url":"https://www.ema.europa.eu/en/documents/report/shortages-output-json-report_en...","shortages_data_timestamp":"2026-11-06T06:05:23Z"},"shortages":{"by_status":{"To Be Discontinued":3},"shortages":[{"status":"To Be Discontinued","update_date":"2026-06-04","availability":null,"company_name":"Novo Nordisk, Inc.","generic_name":"Semaglutide Tablet","presentation":"Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)","related_info":"Discontinuation of the manufacture of the drug. These products will be replac...","shortage_reason":null,"discontinued_date":"2026-06-04","initial_posting_date":"2026-06-04","therapeutic_category":["Endocrinology/Metabolism"]}],"source_url":"https://api.fda.gov/drug/shortages.json?search=generic_name%3A%22semaglutide%...","provided_by":"Bosco Labs (boscolabs.dev)","total_records":3,"data_last_updated":"2026-11-06"},"attribution":"US data: U.S. Food and Drug Administration (FDA) via openFDA (https://open.fd...","provided_by":"Bosco Labs (boscolabs.dev)","retrieved_at":"2026-11-06T08:57:10+00:00","adverse_events":{"source_url":"https://api.fda.gov/drug/event.json?search=patient.drug.openfda.generic_name%...","provided_by":"Bosco Labs (boscolabs.dev)","reports_total":86031,"top_reactions":[{"reaction":"NAUSEA","report_count":12276,"share_of_reports":0.1427}],"serious_reports":45165,"data_last_updated":"2026-10-28"},"schema_version":"1","failed_sections":[]}],"tool":"drug-safety","count":1,"message":"","paid_via":"x402","warnings":[],"balance_usd":0,"charged_usd":0.02,"duration_seconds":1.2}},"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.02","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.02/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.02","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.02","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_KiWjPvNykHHmZm4ZKhduD","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.02","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Retrieves FDA adverse event reports, boxed warnings, drug recalls, shortages, and EU authorization status for a single drug from official sources (openFDA and EMA).","exampleAgentPrompt":"Pull the full FDA drug safety dossier for semaglutide — I need the boxed warning, top adverse events, any active recalls, shortage info, and EU authorization status.","exampleUseCases":[{"title":"Pre-prescribing safety check","prompt":"Before my research review, can you get the full safety dossier for atorvastatin — I want to see the boxed warning, top reported adverse reactions from FAERS, and any recent FDA recalls?"},{"title":"EU market authorization verification","prompt":"I need to know whether pembrolizumab is currently authorized in the EU and if there are any active shortages — can you check the official EMA status?"},{"title":"Drug recall monitoring for compounding pharmacy","prompt":"Pull up all current FDA recalls for semaglutide and tell me the classification, reason, and recalling firm for each — I need up to 20 results."}],"resultDescription":"A JSON response with a 'rows' array containing the drug match metadata and one or more populated sections depending on mode: label details (routes, indications, boxed warning, brand names, application number), top FAERS adverse reactions, recall records (status, classification, firm, reason), shortage data, and EU authorization status — each row includes source URLs pointing to the official FDA or EMA data.","failureModes":["Drug name not found in FDA or EMA databases — returns empty result with no charge","Misspelled or ambiguous drug name may match wrong compound","API returns error on malformed drug string (e.g. contains brackets or special characters)","EU section may be absent if drug has no EMA record","No charge on error or empty result, but partial results may still be billed for delivered rows"],"whenToPreferThis":"Use this endpoint when you need official FDA and EMA drug safety data — adverse events, boxed warnings, recalls, shortages, and EU authorization — aggregated into a single call per drug. Prefer this over general web search when you need structured, source-cited regulatory data from openFDA and EMA rather than editorial summaries. Ideal for pharmaceutical research workflows, compliance checks, and agent pipelines that require auditable official-source citations.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-11-13T12:46:42.249Z","isFirstParty":false,"canonicalSlug":"fda-adverse-events-drug-safety-faers-ema-dbed0ed7"}